Literature DB >> 4606

Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.

M D Adams, J T Earnhardt, W L Dewey, L S Harris.   

Abstract

Cardiovascular effects of delta8- and delta9-tetrahydrocannabinol (THC) were studied after systemic intravenous administration and intra-arterial administration into a perfused vascular bed in the urethane-anesthetized rat. Intravenous administration of delta8- and delta9-THC produced dose-related transient increases in blood pressure followed by more prolonged hypotensive responses and bradycardia. Intra-arterial administration of delta8- and delta9-THC into the perfused hindquarters of the rat produced an increase in perfusion pressure indicative of vasoconstriction. The vasoconstrictor response to the cannabinoids corresponded temporally to a similar response produced by i.a. norepinephrine and was in contrast to the more prolonged vasoconstrictor responses produced by vasopressin. Phentolamine, in a dose which reduced the vasoconstrictor effect of norepinephrine by 90%, significantly reduced the response to i.a. delta9-THC while having no effect on the actions of i.a. vasopressin. It was demonstrated that reserpine pretreatment significantly reduced vasoconstrictor actions of i.a. tyramine and delta9-THC but did not alter the responses to norepinephrine. These data suggest that delta8- and delta9-THC have peripheral vasoconstrictor activity in the rat which may be mediated, in part, through a tyramine-like action on adrenergic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4606

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

Review 1.  Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

Authors:  Barbara Malinowska; Marta Baranowska-Kuczko; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat.

Authors:  E A Stein; S A Fuller; W S Edgemond; W B Campbell
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Cannabis arteritis: ever more important to consider.

Authors:  Rui Pedro Santos; Cristina Isabel Pinho Resende; Ana Paula Vieira; Celeste Brito
Journal:  BMJ Case Rep       Date:  2017-03-13

4.  Do cannabinoids exhibit a tyramine-like effect?

Authors:  Eman Ilayan; Monika Feliszek; Barbara Malinowska; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-07-31       Impact factor: 3.000

Review 5.  Cerebrovascular Complications Associated with Marijuana Use.

Authors:  Bayan Moustafa; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2021-04-07       Impact factor: 5.081

6.  Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.

Authors:  Michael S Smirnov; Eugene A Kiyatkin
Journal:  Brain Res       Date:  2008-06-26       Impact factor: 3.252

7.  Histamine release in dogs by Emulphor EL620.

Authors:  J W Constantine; W S Lebel
Journal:  Experientia       Date:  1979-03-15

8.  Endocannabinoids protect the rat isolated heart against ischaemia.

Authors:  Philippe Lépicier; Jean-François Bouchard; Caroline Lagneux; Daniel Lamontagne
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

9.  Cannabis arteritis.

Authors:  Naoual El Omri; Rachid Eljaoudi; Fadwa Mekouar; Mohammed Jira; Youssef Sekkach; Taoufik Amezyane; Driss Ghafir
Journal:  Pan Afr Med J       Date:  2017-02-01

Review 10.  A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ⁸-Tetrahydrocannabinol.

Authors:  Salahaden R Sultan; Sophie A Millar; Saoirse E O'Sullivan; Timothy J England
Journal:  Pharmaceuticals (Basel)       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.